NewsBenzingaTwist Bioscience prevede vendite per l’anno fiscale 2027 a 550,000-560,000 milioni di dollari, rispetto ai 547,137 milioni stimati. Twist Bioscience prevede vendite per l’anno fiscale 2027 a 550,000-560,000 milioni di dollari, rispetto ai 547,137 milioni stimati. Benzinga 2026.11.12 12:18 (GMT+0) Open on Benzinga Other news David Einhorn Bets on Aluminum in Q3: Here Are His New Stock Picks, Fund Changes Bernstein Maintains Market Perform on Tyson Foods, Raises Price Target to $72 Broadcom Stock Is Up Tuesday: AI Chip Diversification, Dec. 9 Earnings, Analyst Targets Bernstein Downgrades PepsiCo to Underperform, Lowers Price Target to $128 If You Invested $1000 In Humana Stock 20 Years Ago, You Would Have This Much Today What's Going On With Ouster Stock Tuesday?